U.S. Senator Tammy Baldwin Calls on Pharmaceutical Companies to Explain Skyrocketing Insulin Prices
Senators: “It is clear that these steep price increases are resulting in patients lacking access to the life-saving medications they need.”
WASHINGTON, D.C. – U.S. Senator Tammy Baldwin (D-WI), a member of the Senate Health, Education, Labor, and Pensions (HELP) Committee, joined her colleagues to call on executives at Eli Lilly, Novo Nordisk, and Sanofi— the three insulin manufacturers in the U.S.—demanding information about rising insulin costs and questioning the companies that recently decided to raise prices for the life-saving drug even further.
“According to the World Health Organization, insulin is an essential medicine, meaning that access to this drug at a price that individuals and communities can afford is a basic requirement of a functioning health care system. Unfortunately, rapidly increasing insulin prices mean that for many patients, access to this essential medicine is threatened. Patients have had to resort to desperate measures when confronted with increased insulin prices or high cost-sharing for their prescriptions. Some patients have turned to GoFundMe pages to request help paying for insulin, and one in four diabetic patients report rationing the medication because of the cost, with potentially devastating consequences. It is clear these steep price increases are resulting in patients lacking access to the life-saving medications they need,” wrote the Senators.
The letter was also signed by Senators Bob Casey (D-PA), Maggie Hassan (D-NH), Doug Jones (D-AL), Tim Kaine (D-VA), Chris Murphy (D-CT), Patty Murray (D-WA), Jacky Rosen (D-NV), Bernie Sanders (I-VT), Tina Smith (D-MN) and Elizabeth Warren (D-MA).
The letters are available below.
- A PDF of the letter to Eli Lilly is available here.
- A PDF of the letter to Novo Nordisk is available here.
- A PDF of the letter to Sanofi is available here.
NOTE: This press release was submitted to Urban Milwaukee and was not written by an Urban Milwaukee writer. While it is believed to be reliable, Urban Milwaukee does not guarantee its accuracy or completeness.
Mentioned in This Press Release
Recent Press Releases by U.S. Sen. Tammy Baldwin
Baldwin, Colleagues Force Vote on Trump’s Illegal War in Iran
Mar 18th, 2026 by U.S. Sen. Tammy BaldwinWATCH: Baldwin takes to Senate Floor to advocate against Trump’s war of choice
Baldwin Successfully Pushes Trump Admin to Release $1 Billion for Blatnik Bridge
Mar 18th, 2026 by U.S. Sen. Tammy BaldwinBaldwin voted to pass the Bipartisan Infrastructure Law, has relentlessly fought to fund Blatnik Bridge project under Biden and Trump.
Baldwin to Trump: Back My Bill to Support Made in USA Products Online
Mar 17th, 2026 by U.S. Sen. Tammy BaldwinPresident Trump’s Executive Order aligns with Baldwin’s bipartisan bill requiring online retailers to clearly disclose their country of origin
